The impact of race on biochemical disease-free survival in early-stage prostate cancer patients treated with surgery or radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 45, Issue 5, 1999, Pages 1235-1238

  Hart, Kimberly B ^a   Wood Jr , David P ^b   Tekyi Mensah, Samuel ^a   Porter, Arthur T ^a   Pontes, J Edson ^b   Forman, Jeffrey D ^a  

^a Depts Ofradiation Oncol Barbara A   (United States)

^b Barbara Ann Karmanos Cancer I   (United States)

Author keywords

Prostate cancer; Race

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUCASIAN; DOSE RESPONSE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; RADIATION DOSE; TREATMENT OUTCOME;

AFRICAN CONTINENTAL ANCESTRY GROUP; DISEASE-FREE SURVIVAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 0032804105     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00321-1     Document Type: Article

References (22)

1. Wingo P.A., Bolden S., Tong T., et al. Cancer statistics for African-Americans. Cancer. 46:1996;113.
2. Optenberg S.A., Thompson I.M., Fredricks P., et al. Race, treatment and long-term survival from prostate cancer in an equal access medical care delivery system. JAMA. 274:1995;1599-1605.
3. Moul J.W., Sesterhenn I.A., Connelly R.R., et al. Prostate specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA. 274:1995;1277-1281.
4. Miller BA, Ries LAG, Hankey BF; et al. SEER Cancer Statistics Review: 1973-1990. National Cancer Institute, NIH Publication #93-2789;1993.
5. Moul J.W., Douglas T.H., McCarthy W.F., et al. Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access care setting. J Urol. 155:1996;1667-1673.
6. Roach M., Krall J., Keller J.W., et al. The prognostic significance of race and survival from prostate cancer based on patients irradiated in RTOG Protocols. Int J Radiat Oncol Biol Phys. 24:1992;441-449.
7. Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys 1997:1035-1041.
8. Asbell S.O., Vijayakumar S. Racial differences in prostate specific antigen levels in patients with local regional prostate cancer. Prostate. 31:1997;42-46.
9. Henderson R.J., Eastham J.A., Culkin D.J., et al. Prostate specific antigen and PSA density - racial differences in men without prostate cancer. JNCI. 89:1997;134-138.
10. Morgan T.O., Jacobsen S.D., McCarthy W.F., et al. Age-specific reference ranges for serum prostate specific antigen in Black men. N Engl J Med. 335:1996;304-310.
11. Vijayakumar S., Winter K., Sause W., et al. Prostate specific antigen levels are higher in African-Americans than in White patients in a multicenter registration study - results of RTOG 94-12. Int J Radiat Oncol Biol Phys. 40:1998;17-25.
12. Aziz H., Rotman M., Thelmo W., et al. Radiation treated carcinoma of the prostate - comparison of survival of black and white patients by Gleason grading system. Am J Clin Oncol. 11:1988;166-171.
13. Sakr W., Haas G.P., Cassin B.P. The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol. 150:1993;379-385.
14. Demark-Wahnefried W., Strigo T., Catoe K., et al. Knowledge, beliefs and prior screening behavior among Blacks and Whites reporting for prostate cancer screening. Urology. 46:1995;346-351.
15. Myers R.E., Wolf T.A., Balshem A.M., et al. Receptivity of African-American men to prostate cancer screening. Urology. 1994;480-487.
16. Harlan L., Brawley O., Pommerenke F., et al. Geographic, age and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol. 13:(1):1995;95-100.
17. Mettlin C., Murphy G.P., McGinnis L.S., et al. The National Cancer Data Base Report on carcinoma of the prostate. Cancer. 76:1995;1104-1112.
18. Kim J.A., Kuban D.A., el-Mahdi A.M., et al. Carcinoma of the prostate - race as a prognostic indicator in definitive radiation therapy. Radiology. 194:1995;545-549.
19. Austin J.P., Aziz H., Potters L. Diminished survival of young blacks with adenocarcinoma of the prostate. Am J Clin Oncol. 1990;465-469.
20. Powell I. Prostate cancer and African-American males. Oncology. 11:1997;599-605.
21. Fowler J.E., Terrell F. Survival in Blacks and Whites after treatment for localized carcinoma of the prostate. J Urol. 156:1996;133-136.
22. Hart K.B., Porter A.T., Shamsa F., et al. The influence of race on the presentation and natural history of prostate cancer. Semin Urol Oncol. 16:(4):1998;227-231.